Rasagiline mesylate
- Product NDC
- 23155-747
- 11-digit product format
- 231550747
- Labeler code
- 23155
- Product ID
- 23155-747_bec7650d-c8a3-4841-8d06-5f2779961fb6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rasagiline mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Avet Pharmaceuticals Inc.
- Application
- ANDA206153
- Marketing category
- ANDA
- Marketing start
- 2023-05-31
- Marketing end
- 2026-07-31
- Substance
- RASAGILINE MESYLATE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rasagiline mesylate
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RASAGILINE MESYLATE | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LH8C2JI290 |
| Rxcui | 608328, 636664 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 23155-747-03 | Rasagiline mesylate | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 23155-747 | RASAGILINE MESYLATE TABLET [AVET PHARMACEUTICALS INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20231030_7d070521-ea04-4483-bdb9-54a8859700df.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 23155-747-03 | 23155074703 | 30 TABLET in 1 BOTTLE (23155-747-03) | 30 tablet | 2023-10-23 | 2026-07-31 | No | No | Current |